Literature DB >> 20373091

Chemokines in angiogenesis.

Anna Dimberg1.   

Abstract

Chemokines are a family of small heparin-binding proteins, mostly known for their role in inflammation and immune surveillance, which have emerged as important regulators of angiogenesis. Chemokines influence angiogenesis either through recruitment of pro-angiogenic immune cells and endothelial progenitors to the neo-vascular niche or via direct regulation of endothelial function downstream of activation of G-protein coupled chemokine receptors. The dual function of chemokines in regulating immune response and angiogenesis confers a central role in modulating the tissue microenvironment. Therefore, chemokines may constitute attractive targets for therapeutic intervention in several pathological disorders. This review will summarize the current understanding of the role of chemokines in angiogenesis, and give an overview of angiostatic and angiogenic chemokines and their crosstalk with other angiogenic factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373091     DOI: 10.1007/82_2010_21

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  37 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

Review 2.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

3.  Chemokine programming dendritic cell antigen response: part I - select chemokine programming of antigen uptake even after maturation.

Authors:  Jaehyung Park; Cindy T Wu; James D Bryers
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

4.  Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies.

Authors:  Simon Kaja; Jill D Hilgenberg; Eric Everett; Scott E Olitsky; Jim Gossage; Peter Koulen
Journal:  Hum Antibodies       Date:  2011

Review 5.  Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience.

Authors:  Knut Liseth; Elisabeth Ersvaer; Tor Hervig; Øystein Bruserud
Journal:  J Biomed Biotechnol       Date:  2010-06-02

6.  Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals.

Authors:  Najib Aziz; Roger Detels; L Cindy Chang; Anthony W Butch
Journal:  J AIDS Clin Res       Date:  2016-06-14

7.  IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.

Authors:  Fabrizio Mattei; Giovanna Schiavoni; Paola Sestili; Francesca Spadaro; Alessandra Fragale; Antonella Sistigu; Valeria Lucarini; Massimo Spada; Massimo Sanchez; Stefania Scala; Angela Battistini; Filippo Belardelli; Lucia Gabriele
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

8.  SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

Authors:  Andreas Stahl; Jean-Sebastian Joyal; Jing Chen; Przemyslaw Sapieha; Aimee M Juan; Colman J Hatton; Dorothy T Pei; Christian G Hurst; Molly R Seaward; Nathan M Krah; Roberta J Dennison; Emily R Greene; Elisa Boscolo; Dipak Panigrahy; Lois E H Smith
Journal:  Blood       Date:  2012-07-12       Impact factor: 22.113

Review 9.  Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment.

Authors:  Guangna Liu; Wei Rui; Xueqiang Zhao; Xin Lin
Journal:  Cell Mol Immunol       Date:  2021-03-30       Impact factor: 11.530

10.  Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment.

Authors:  Qi Li; Jinhao Hu; Yibo Shi; Mulun Xiao; Tianxiang Bi; Chaoliang Wang; Liang Yan; Xiaoyan Li
Journal:  Cell Cycle       Date:  2021-11-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.